News tagged with monotherapy

Added benefit of dapagliflozin is not proven

Dapagliflozin (trade name: Forxiga) has been approved in Germany since November 2012 for the treatment of type 2 diabetes mellitus. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal ...

Jun 06, 2013
popularity not rated yet | comments 0

A more ethical way to compare epilepsy treatments

For the first time, a new research methodology recently approved by the Food and Drug Administration has been used to demonstrate that converting patients from one anti-epileptic drug to another - in this case, lamotrigine ...

Dec 05, 2011
popularity not rated yet | comments 0